Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Benjamin M. McLeod"'
Autor:
Sylvia P. Thomas, Marcus M. Spinelli, Amira D. Rghei, Jordyn A. Lopes, Nicole Zielinska, Benjamin M. McLeod, Yanlong Pei, Wei Zhang, Bernard Thebaud, Khalil Karimi, Sarah K. Wootton
Publikováno v:
BMC Biotechnology, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background The advancement of AAV vectors into clinical testing has accelerated rapidly over the past two decades. While many of the AAV vectors being utilized in clinical trials are derived from natural serotypes, engineered serotypes are p
Externí odkaz:
https://doaj.org/article/2d61c9316007484a9a60b696c9ed9f24
Autor:
Amira D. Rghei, Laura P. van Lieshout, Benjamin M. McLeod, Yanlong Pei, Jordyn A. Lopes, Nicole Zielinska, Enzo M. Baracuhy, Brenna A. Y. Stevens, Sylvia P. Thomas, Jacob G. E. Yates, Bryce M. Warner, Darwyn Kobasa, Hugues Fausther-Bovendo, Gary P. Kobinger, Khalil Karimi, Brad Thompson, Byram W. Bridle, Leonardo Susta, Sarah K. Wootton
Publikováno v:
Biomedicines, Vol 9, Iss 9, p 1186 (2021)
Adeno-associated virus (AAV) vector mediated expression of therapeutic monoclonal antibodies is an alternative strategy to traditional vaccination to generate immunity in immunosuppressed or immunosenescent individuals. In this study, we vectorized a
Externí odkaz:
https://doaj.org/article/f323e697c3344c79998e1eb3bd389d59
Autor:
Byram W. Bridle, Brenna A Y Stevens, Khalil Karimi, Sylvia P. Thomas, Benjamin M. McLeod, Jacob G. E. Yates, Sarah K. Wootton, Amira D Rghei, Leonardo Susta
Publikováno v:
Journal of Visualized Experiments.
Adeno-associated virus (AAV) vectors are among the most clinically advanced gene therapy vectors, with three AAV gene therapies approved for humans. Clinical advancement of novel applications for AAV involves transitioning from small animal models, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c254b755899582e12aff9bd23859bc
https://doi.org/10.3791/62727-v
https://doi.org/10.3791/62727-v
Autor:
Leonardo Susta, Brenna A Y Stevens, Jordyn A. Lopes, Jacob G. E. Yates, Enzo M. Baracuhy, Sarah K. Wootton, Byram W. Bridle, Darwyn Kobasa, Nicole Zielinska, Laura P. van Lieshout, Khalil Karimi, Benjamin M. McLeod, Gary P. Kobinger, Hugues Fausther-Bovendo, Amira D Rghei, Yanlong Pei, Brad Thompson, Bryce M. Warner, Sylvia P. Thomas
Publikováno v:
Biomedicines
Biomedicines, Vol 9, Iss 1186, p 1186 (2021)
Volume 9
Issue 9
Biomedicines, Vol 9, Iss 1186, p 1186 (2021)
Volume 9
Issue 9
Adeno-associated virus (AAV) vector mediated expression of therapeutic monoclonal antibodies is an alternative strategy to traditional vaccination to generate immunity in immunosuppressed or immunosenescent individuals. In this study, we vectorized a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::302ea1ec25d840cf9a0940d2bb76cc06
https://doi.org/10.3390/biomedicines9091186
https://doi.org/10.3390/biomedicines9091186